<?xml version="1.0" encoding="UTF-8"?>
<p>The selected active samples were then reformatted into new 96-well plates and tested against PR8-PB2-Gluc at 25 μg/mL in 0.125% DMSO (v/v) to confirm the primary results. Cell cytotoxicity was examined 48 h post-treatment using the CellTiter-Glo
 <sup>®</sup> Luminescent Cell Viability Assay (Promega, Madison, WI, United States), treated for the antiviral screen.
</p>
